Literature DB >> 11939726

Papanicolaou tests diagnosed as atypical by a cytotechnologist and downgraded to benign by a pathologist: a measure of laboratory quality.

Jennifer L Condel1, Laura K Mahood, Dana M Grzybicki, Charles D Sturgis, Stephen S Raab.   

Abstract

Follow-up of Papanicolaou (Pap) tests diagnosed as atypical squamous cells of undetermined significance (ASCUS) or atypical glandular cells of undetermined significance (AGUS) by a cytotechnologist and downgraded to benign by a pathologist has not been measured. Squamous intraepithelial lesion (SIL) follow-up rates were obtained for Pap tests diagnosed as ASCUS (288) or AGUS (94) and downgraded to benign and for Pap tests diagnosed as repair (231). Statistically significant associations were seen between 7 cytotechnologists and between 7 pathologists and ASCUS, AGUS, downgraded ASCUS, and downgraded AGUS rates. The percentage of downgraded ASCUS cases compared with all ASCUS cases per pathologist ranged from 4.8% to 43.7%. Statistically significant associations between pathologists and SIL follow-up rates for downgraded ASCUS diagnoses were seen. The SIL follow-up rate for repair (7.9%) was similar to that for a downgraded ASCUS (11.0%) or AGUS (7.3%). The parameters of downgraded ASCU and AGUS Pap test interpretations are good quality indicators of individual performance and overall laboratory quality.

Entities:  

Mesh:

Year:  2002        PMID: 11939726     DOI: 10.1309/WVW0-48TJ-E7VA-DM8R

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.

Authors:  Ye-Li Yao; Qi-Fang Tian; Bei Cheng; Yi-Fan Cheng; Jing Ye; Wei-Guo Lu
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

2.  MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women.

Authors:  Qifang Tian; Yang Li; Fenfen Wang; Ying Li; Junfen Xu; Yuanming Shen; Feng Ye; Xinyu Wang; Xiaodong Cheng; Yaxia Chen; Xiaoyun Wan; Weiguo Lu; Xing Xie
Journal:  J Natl Cancer Inst       Date:  2014-09-04       Impact factor: 13.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.